Catherine Dunn

Catherine Dunn

Reporter

LATEST ARTICLES

Eli Lilly, GLP-1 Troubles Are Dragging Down This Healthcare ETF

Eli Lilly, GLP-1 Troubles Are Dragging Down This Healthcare ETF

Eli Lilly faces challenges in the GLP-1 market, with Novo Nordisk gaining a timing advantage in both injectable and oral drug approvals.

2 minute read

Hantavirus: What to Know About the Virus—and Why Moderna Stock Rallied

Hantavirus: What to Know About the Virus—and Why Moderna Stock Rallied

Evercore ISI analysts cautioned investors, writing Thursday that “with regards to current headlines, we see no meaningful revenue opportunity.”

2 minute read

CVS Health Stock Jumps After Earnings. What’s Encouraging Wall Street.

CVS Health Stock Jumps After Earnings. What’s Encouraging Wall Street.

CVS Health’s Aetna was the third-largest provider of Medicare Advantage plans in 2025, behind UnitedHealth Group and Humana.

3 minute read

Why UnitedHealth Made Goldman’s Top Buy List

Why UnitedHealth Made Goldman’s Top Buy List

The insurance company has plans to get smaller in Medicare Advantage. Goldman Sachs likes the idea.

2 minute read

Health Insurer Cigna Tops Estimates. Why the Stock Is Falling.

Health Insurer Cigna Tops Estimates. Why the Stock Is Falling.

The company modestly raised its forecast for 2026 profits amid a shift in its drug pricing and CEO transition.

2 minute read

Humana Earnings Beat Estimates. The Stock Is Gaining.

Humana Earnings Beat Estimates. The Stock Is Gaining.

The stock has slumped this year, seesawing on news of how much the government plans to pay insurers that operate Medicare Advantage health plans for seniors.

3 minute read

Regeneron Shares Up on Trump Drug Pricing Deal

Regeneron Shares Up on Trump Drug Pricing Deal

Regeneron, in a press release, said it would get tariff relief for three years under terms with the U.S. Department of Commerce.

2 minute read

UnitedHealth Stock Pops on Turnaround Progress

UnitedHealth Stock Pops on Turnaround Progress

The health insurer cites improvements in Medicare Advantage and says it’s making $1.5 billion in AI investments.

Long Read

RFK Jr. Defends Health Budget Cuts Before House Committee

RFK Jr. Defends Health Budget Cuts Before House Committee

The health secretary told lawmakers the department’s proposed budget focuses on prevention because it has better outcomes than treatment.

2 minute read

Health Stocks Get a Boost From New Medicare Rate

Health Stocks Get a Boost From New Medicare Rate

About 35 million beneficiaries are in Medicare Advantage plans this year, according to the health research group KFF.

3 minute read

CVS Health and FTC Staff Agree to Proposed Insulin Settlement

CVS Health and FTC Staff Agree to Proposed Insulin Settlement

The agreement would cover the company’s Caremark pharmacy benefit manager unit, which has denied wrongdoing.

1 minute read

Google Partners With CMS on Linking Medical Records to Fitbit

Google Partners With CMS on Linking Medical Records to Fitbit

One feature will allow Fitbit users to share their medical records with the app’s AI-powered health coach.

2 minute read

DOJ Settles Medicare Advantage Claims With CVS Health’s Aetna

DOJ Settles Medicare Advantage Claims With CVS Health’s Aetna

Aetna paid a $117.7 million settlement over allegations it submitted inaccurate diagnosis code to inflate Medicare payments.

1 minute read

Rubio Addresses Security Conference After a Year of Rising Tensions

Rubio Addresses Security Conference After a Year of Rising Tensions

Vice President JD Vance shocked Europeans in at last year’s conference, saying the biggest threat to the continent isn’t China or Russia, but a turn away from “democratic values.”

2 minute read

Healthcare Rules the Jobs Market. This Is What’s Driving the Gains.

Healthcare Rules the Jobs Market. This Is What’s Driving the Gains.

Midlevel healthcare jobs more than doubled between 2010 and 2022.

2 minute read

Moderna Stock Sinks. Its Flu Vaccine Was Rejected.

Moderna Stock Sinks. Its Flu Vaccine Was Rejected.

The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.

2 minute read

Humana Loss Was Narrower Than Expected

Humana Loss Was Narrower Than Expected

Humana shares are down more than 30% since the federal government announced plans last month to keep Medicare Advantage rates nearly flat in 2027.

2 minute read

How UnitedHealth’s Comeback Ran Aground

How UnitedHealth’s Comeback Ran Aground

UnitedHealth Group‘s latest selloff is one more painful moment in a run of tough times for the stock.

Long Read

UnitedHealth and CVS Get Grilled on Affordability by Congress

UnitedHealth and CVS Get Grilled on Affordability by Congress

The CEOs of large health insurers testified Thursday on Capitol Hill amid a rising focus on healthcare costs.

2 minute read

of 3 pages